Skip to main content

Table 1 Patient details and clinicopathological features

From: Inducing multiple antibodies to treat squamous cell esophageal carcinoma

  Esophageal cancer
Number 85
Gender
 Male 73 (85.9%)
 Female 12 (14.1%)
Mean age ± s.d. (years) 68.2 ± 7.7
Age range (years) 45–85
Depth of tumor invasion
 T1 28 (32.9%)
 T2 8 (9.4%)
 T3 29 (34.1%)
 T4 20 (23.5%)
Lymph node metastasis
 Positive 56 (65.9%)
 Negative 29 (34.1%)
Distant metastasis
 Positive 19 (22.4%)
 Negative 66 (77.6%)
TNM stage
 I 26 (30.6%)
 II 7 (8.2%)
 III 19 (22.4%)
 IV 33 (38.8%)